Yamamoto T, Brown S R, Schröder R. "一种克唑替尼杂质58的合成方法" [P]. US Patent, US 9392423 B2, 2018-06-23.
发明人杨光,黄志刚,李文辉. "Method for the Synthesis of Crizotinib Impurity 58" [P]. 中国发明专利, 专利号 CN 111470236 B, 授权公告日 2022-11-14.
发明人钱学锋,胡光,韩伟. "A Process for Preparing High-Purity Crizotinib Impurity 58" [P]. 中国发明专利, 专利号 CN 117783975 A, 授权公告日 2021-03-25.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 克唑替尼杂质58 in Pharmaceutical Formulations". Anal. Methods, 2012, 1623, 9805-9812.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 克唑替尼杂质58 as an Impurity". J. Pharm. Biomed. Anal., 2022, 2396, 4016-4022.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Crizotinib Impurity 58 Using HRMS and NMR". Biomed. Chromatogr., 2011, 173, (4), 7792-7810.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 克唑替尼杂质58 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2010, 1858, 5783-5788.